Take a look around.
Bayer presents new analyses for Vitrakvi® (larotrectinib) in adult and pediatric patients with TRK fusion cancer with solid tumors, and new data in primary central nervous system tumors and brain metastases
Bayer today announced findings from new analyses and data for Vitrakvi® (larotrectinib), which is approved for the treatment of adult and pediatric patients with solid tumors that have a...Learn more
Bayer, Grimmway Farms Bring Salad Bars to Rosedale Union Schools
Bayer is donating salad bars to four schools in the Rosedale Union School District of Bakersfield, California as a strategy to increase children's access and consumption of fresh fruits and...Learn more
Explore Our Divisions
In line with our mission “Bayer: Science for A Better Life,” we aim to improve people’s quality of life.